Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3)

Van Cutsem, Eric; Labianca, Roberto; Hossfeld, D; Bodoky, G.; Roth, A; Aranda, Enrique; Nordlinger, Bernard; Assadourian, Sylvie; Wang, K.; Cunningham, David

doi:10.1200/jco.2005.23.16_suppl.lba8

Public

Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3)

Shared by NobleBlocks on Jun 1, 2005 • 12:00 AM UTC

Authors:

Eric Van Cutsem

Roberto Labianca

D Hossfeld

Abstract

LBA8 Background: Infused irinotecan regimens have improved survival in metastatic CRC. This international, multicenter, open-label, randomized, prospective trial of adjuvant chemotherapy with IF vs. F was designed to confirm these results in pts with stage III colon cancer. Pts were given IF (Arm A)...

Subject

Medicine

Irinotecan

Regimen

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!